Stay updated on Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Sign up to get notified when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.
Latest updates to the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check14 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has removed a detailed section regarding data download options and study information fields, which may affect users looking for specific data formats and study details.SummaryDifference13%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and enhanced data field selection for studies.SummaryDifference16%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
- Check58 days agoChange DetectedA new version (v2.12.0) of the Phase II study on Ponatinib combined with Mini-hyper CVD Chemotherapy and Venetoclax for T-cell Acute Lymphoblastic Leukemia has been added, replacing the previous version (v2.11.2) from September.SummaryDifference2%
Stay in the know with updates to Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib, Mini-hyper CVD, Venetoclax in T-ALL Clinical Trial page.